1)島崎 潤:要注意:薬物アレルギー.皮膚科診療プラクティス2(粘膜病変を診る):162-165,1998
2)松永佳世子・鈴木加余子:要注意:薬物アレルギー.皮膚科診療プラクティス2(粘膜病変を診る):253-257,1998
3)岡本茂樹:接触性皮膚炎(点眼薬アレルギー)の診療指針.あたらしい眼科 22:745-748,2005
4)大井綱郎:薬疹の診断法.MB Derma 10:15-21,1998
5)Sasaki S, Mitsuhashi Y, Kondo S:Contact dermatitis due to sodium bisulfite in an ophthalmic solution. J Dermatol 24:675-677, 1997
6)Hwu JJ, Chen KH, Hsu WM et al:Ocular hypersensitivity to topical vancomycin in a case of chronic endophthalmitis. Cornea 24:754-756, 2005
7)Chaudhari PR, Maibach H:Allergic contact dermatitis from ophthalmics:2007. Contact Dermatitis 57:11-13, 2007
8)Jerstad KM, Warshaw E:Allergic contact dermatitis to latanoprost. Am J Contact Dermat 13:39-41, 2002
9)Lai CH, Lai IC, Chi CC:Allergic contact dermatitis caused by latanoprost ophthalmic solution. Eur J Ophthalmol 16:627-629, 2006
10)廣門未知子・川口とし子・金井 光:緑内障点眼剤による接触性皮膚炎の5例.皮膚臨床 48:773-776,2006
11)松谷 紫・今村隆志・麻上千鳥・他:抗アレルギー点眼剤中の塩化ベンザルコニウムによる眼周囲アレルギー性接触皮膚炎.西日本皮膚 56:3-6,1994
12)宇宿一成:塩化ベンザルコニウムによる接触性皮膚炎を生じた放射線皮膚潰瘍の1例.臨皮 61:680-682,2007
13)Imokawa G, Abe A, Jin K et al:Decreased level of ceramides in stratum corneum of atopic dermatitis:An etiologic factor in atopic dry skin? J Invest Dermatol 96:523-526, 1991
14)Palmer CN, Irvine AD, Terron-Kwiatkowski A et al:Common loss-of-function variants of the epidermal barrier protein filaggrin are major predisposing factor for atopic dermatitis. Nat Genet 38:441-446, 2006
15)高村悦子:アトピー性皮膚炎の対処法.皮膚科診療プラクティス2(粘膜病変を診る):181-185,1998
16)山川有子:アトピー性皮膚炎と接触アレルギー―air borneを含めて.皮膚病診療 28:83-88,2006